The following scientific references were used in the development of the program, From Anxious to Happy.
1. Neugebauer, V., Li, W., Bird, G. C., & Han, J. S. (2004). The amygdala and persistent pain. Neuroscientist, 10(3), 221-234..
2. Dyrbye, L. N., Thomas, M. R., & Shanafelt, T. D. (2006) Systematic review of depression, anxiety, and other indicators of psychological distress among U.S. and canadian medical students. Academic Medicine, 81(4), 354-373.
3. Mirza, I., & Jenkins, R. (2004). Risk factors, prevalence, and treatment of anxiety and depressive disorders in pakistan: Systematic review. British Medical Journal, 328(7443), 794-797.
4. Somers, J. M., Goldner, E. M., Waraich, P., & Hsu, L. (2006). Prevalence and incidence studies of anxiety disorders: A systematic review of the literature. Canadian Journal of Psychiatry, 51(2), 100-113.
5. Goldfarb, M. R., Trudel, G., Boyer, R., & Préville, M. (2007). Marital relationship and psychological distress: Its correlates and treatments. Sexual and Relationship Therapy, 22(1), 109-126.
6. Hunter, E. C. M., Sierra, M., & David, A. S. (2004). The epidemiology of depersonalisation and derealisation – A systematic review. Social Psychiatry and Psychiatric Epidemiology, 39(1), 9-18.
7. Cassidy, E. L., Lauderdale, S., & Sheikh, J. I. (2005). Mixed anxiety and depression in older adults: Clinical characteristics and management. Journal of Geriatric Psychiatry and Neurology, 18(2), 83-88.
8. Davidson, J. R. T., Connor, K. M., & Swartz, M. (2006). Mental illness in U.S. presidents between 1776 and 1974: A review of biographical sources. Journal of Nervous and Mental Disease, 194(1), 47-51.
9. Grigsby, A. B., Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2002). Prevalence of anxiety in adults with diabetes a systematic review. Journal of Psychosomatic Research, 53(6), 1053-1060.
10. Katerndahl, D. (2004). Panic & plaques: Panic disorder & coronary artery disease in patients with chest pain. Journal of the American Board of Family Practice, 17(2), 114-126.
11. Olatunji, B. O., Cisler, J. M., & Tolin, D. F. (2007). Quality of life in the anxiety disorders: A meta-analytic review. Clinical Psychology Review, 27(5), 572-581.
12. Mohlman, J., & Price, R. (2006). Recognizing and treating late-life generalized anxiety disorder: Distinguishing features and psychosocial treatment. Expert Review of Neurotherapeutics, 6(10), 1439-1445.
13. Kessler, R. C. (2007). The global burden of anxiety and mood disorders: Putting the european study of the epidemiology of mental disorders (ESEMeD) findings into perspective. Journal of Clinical Psychiatry, 68(SUPPL. 2), 10-19.
14. Middeldorp, C. M., Cath, D. C., Van Dyck, R., & Boomsma, D. I. (2005). The co-morbidity of anxiety and depression in the perspective of genetic epidemiology. A review of twin and family studies. Psychological Medicine, 35(5), 611-624.
15. Joyce, A. S., Wolfaardt, U., Sribney, C., & Aylwin, A. S. (2006). Psychotherapy research at the start of the 21st century: The persistence of the art versus science controversy. Canadian Journal of Psychiatry, 51(13), 797-809.
16. Ng, H. M., & Bornstein, R. F. (2005). Comorbidity of dependent personality disorder and anxiety disorders: A meta-analytic review. Clinical Psychology: Science and Practice, 12(4), 395-406.
17. Balon, R. (2005). Measuring anxiety: Are we getting what we need? Depression and Anxiety, 22(1), 1-10.
18. Thibodeau, R., Jorgensen, R. S., & Kim, S. (2006). Depression, anxiety, and resting frontal EEG asymmetry: A meta-analytic review. Journal of Abnormal Psychology, 115(4), 715-729.
19. Vink, D., Aartsen, M. J., & Schoevers, R. A. (2008). Risk factors for anxiety and depression in the elderly: A review. Journal of Affective Disorders, 106(1-2), 29-44.
20. Spira, A. P., Friedman, L., Flint, A., & Sheikh, J. I. (2005). Interaction of sleep disturbances and anxiety in later life: Perspectives and recommendations for future research. Journal of Geriatric Psychiatry and Neurology, 18(2), 109-115.
21. Jensen, P. S., Weersing, R., Hoagwood, K. E., & Goldman, E. (2005). What is the evidence for evidence-based treatments? A hard look at our soft underbelly. Mental Health Services Research, 7(1), 53-74.
22. Mohlman, J. (2005). Does executive dysfunction affect treatment outcome in late-life mood and anxiety disorders? Journal of Geriatric Psychiatry and Neurology, 18(2), 97-108.
23. Ipser, J. C., Dewing, S., & Stein, D. J. (2007). A systematic review of the quality of information on the treatment of anxiety disorders on the internet. Current Psychiatry Reports, 9(4), 303-309.
1. Trzesniak, C., Araújo, D., & Crippa, J. A. S. (2008). Magnetic resonance spectroscopy in anxiety disorders. Acta Neuropsychiatrica, 20(2), 56-71.
2. Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: A meta-ana lysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164(10), 1476-1488.
3. Evans, K., Dougherty, D., Pollack, M., & Rauch, S. (2006). Using neuroimaging to predict treatment response in mood and anxiety disorders. Annals of Clinical Psychiatry, 18(1), 33-42.
4. Malhi, G. S., Valenzuela, M., Wen, W., & Sachdev, P. (2002). Magnetic resonance spectroscopy and its applications in psychiatry. Australian and New Zealand Journal of Psychiatry, 36(1), 31-43.
5. Gittos, M. W. (2006). Toward a better understanding of depression and anxiety: The involvement of stress and tryptophan hydroxylase activation. Drug Development Research, 67(10), 801-805.
1. Hendriks, G. J., Oude Voshaar, R. C., Keijsers, G. P. J., Hoogduin, C. A. L., & Van Balkom, A. J. L. M. (2008). Cognitive-behavioural therapy for late-life anxiety disorders: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 117(6), 403-411.
2. Ernst, E. (2003). Serious psychiatric and neurological adverse effects of herbal medicines – A systematic review. Acta Psychiatrica Scandinavica, 108(2), 83-91.
3. Ernst, E. (2007). Herbal remedies for depression and anxiety. Advances in Psychiatric Treatment, 13(4), 312-316.
4. Lawvere, S., & Mahoney, M. C. (2005). St. john’s wort. American Family Physician, 72(11), 2249-2254.
5. Bent, S., Padula, A., Moore, D., Patterson, M., & Mehling, W. (2006). Valerian for sleep: A systematic review and meta-analysis. American Journal of Medicine, 119(12), 1005-1012.
6. Kaltenthaler, E., Parry, G., & Beverley, C. (2004). Computerized cognitive behaviour therapy: A systematic review. Behavioural and Cognitive Psychotherapy, 32(1), 31-55.
7. Emmanuel, J., Simmonds, S., & Tyrer, P. (1998). Systematic review of the outcome of anxiety and depressive disorders. British Journal of Psychiatry, 173(JULY SUPPL. 34), 35-41.
8. Bower, P., Richards, D., & Lovell, K. (2001). The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: A systematic review. British Journal of General Practice, 51(471), 838-845.
9. Kirkwood, G., Rampes, H., Tuffrey, V., Richardson, J., & Pilkington, K. (2005). Yoga for anxiety: A systematic review of the research evidence. British Journal of Sports Medicine, 39(12), 884-891.
10. Dugoua, J. -., Mills, E., Perri, D., & Koren, G. (2006). Safety and efficacy of st. john’s wort (hypericum) during pregnancy and lactation. Canadian Journal of Clinical Pharmacology, 13(3), e268-e276.
11. Butler, A. C., Chapman, J. E., Forman, E. M., & Beck, A. T. (2006). The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clinical Psychology Review, 26(1), 17-31.
12. Otto, M. W., Smits, J. A. J., & Reese, H. E. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice, 12(1), 72-86.
13. Dhillon, S., Scott, L. J., & Plosker, G. L. (2006). Escitalopram: A review of its use in the management of anxiety disorders. CNS Drugs, 20(9), 763-790.
14. Ipser, J. C., & Stein, D. J. (2006). Newer anticonvulsants in the treatment of anxiety disorders. Cochrane Database of Systematic Reviews, (4)
15. Robinson, J., Biley, F. C., & Dolk, H. (2006). Therapeutic touch for anxiety disorders. Cochrane Database of Systematic Reviews, (4)
16. Ipser, J. C., Carey, P., Dhansay, Y., Fakier, N., Seedat, S., & Stein, D. J. (2006). Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database of Systematic Reviews, (4)
17. Miyasaka, L. S., Atallah, A. N., & Soares, B. G. O. (2006). Valerian for anxiety disorders. Cochrane Database of Systematic Reviews, (4)
18. Kaplan, E. M., & DuPont, R. L. (2005). Benzodiazepines and anxiety disorders: A review for the practicing physician. Current Medical Research and Opinion, 21(6), 941-950.
19. Pull, C. B. (2007). Combined pharmacotherapy and cognitive-behavioural therapy for anxiety disorders. Current Opinion in Psychiatry, 20(1), 30-35.
20. Pull, C. B. (2005). Current status of virtual reality exposure therapy in anxiety disorders. Current Opinion in Psychiatry, 18(1), 7-14.
21. Gorenstein, E. E., & Papp, L. A. (2007). Cognitive-behavioral therapy for anxiety in the elderly. Current Psychiatry Reports, 9(1), 20-25.
22. Stein, D. J. (2003). Algorithm for the pharmacotherapy of anxiety disorders. Current Psychiatry Reports, 5(4), 282-288.
23. Verdeli, H., Mufson, L., Lee, L., & Keith, J. A. (2006). Review of evidence-based psychotherapies for pediatric mood and anxiety disorders. Current Psychiatry Reviews, 2(3), 395-421.
24. Stevinson, C., Huntley, A., & Ernst, E. (2002). A systematic review of the safety of kava extract in the treatment of anxiety. Drug Safety, 25(4), 251-261.
25. Cramer, J. A., De Rue, K., Devinsky, O., Edrich, P., & Trimble, M. R. (2003). A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy and Behavior, 4(2), 124-132.
26. Baldwin, D. S., & Nair, R. V. (2005). Escitalopram in the treatment of generalized anxiety disorder. Expert Review of Neurotherapeutics, 5(4), 443-449.
27. Le Mellédo, J. -., & Baker, G. B. (2004). Role of progesterone and other neuroactive steroids in anxiety disorders. Expert Review of Neurotherapeutics, 4(5), 851-860.
28. van Boeijen, C. A., van Balkom, A. J. L. M., van Oppen, P., Blankenstein, N., Cherpanath, A., & van Dyck, R. (2005). Efficacy of self-help manuals for anxiety disorders in primary care: A sytematic review. Family Practice, 22(2), 192-196.
29. Kaltenthaler, E., Brazier, J., De Nigris, E., Tumur, I., Ferriter, M., Beverly, C., et al. (2006). Computerized cognitive behavior theraphy for depression and anxiety update: A systematic review and economic evaluation. Health Technology Assessment, 10(33), 1-70.
30. Kaltenthaler, E., Shackley, P., Stevens, K., Beverley, C., Parry, G., & Chilcott, J. (2002). A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technology Assessment, 6(22)
31. Ipser, J. C., Kariuki, C. M., & Stein, D. J. (2008). Pharmacotherapy for social anxiety disorder: A systematic review. Expert Review of Neurotherapeutics, 8(2), 235-257.
32. Hansen, R. A., Gaynes, B. N., Gartlehner, G., Moore, C. G., Tiwari, R., & Lohr, K. N. (2008). Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. International Clinical Psychopharmacology, 23(3), 170-179.
33. Stevinson, C., & Ernst, E. (2004). Can st. john’s wort trigger psychoses? International Journal of Clinical Pharmacology and Therapeutics, 42(9), 473-480.
34. Lee, M. S., Pittler, M. H., & Ernst, E. (2008). Effects of reiki in clinical practice: A systematic review of randomised clinical trials. International Journal of Clinical Practice, 62(6), 947-954.
35. Baldwin, D. S., & Polkinghorn, C. (2005). Evidence-based pharmacotherapy of generalized anxiety disorder. International Journal of Neuropsychopharmacology, 8(2), 293-302.
36. Powers, M. B., & Emmelkamp, P. M. G. (2008). Virtual reality exposure therapy for anxiety disorders: A meta-analysis. Journal of Anxiety Disorders, 22(3), 561-569.
37. Nemeroff, C. B. (2005). Use of atypical antipsychotics in refractory depression and anxiety. Journal of Clinical Psychiatry, 66(SUPPL. 8), 13-21.
38. Vermani, M., Milosevic, I., Smith, F., & Katzman, M. A. (2005). Herbs for mental illness: Effectiveness and interaction with conventional medicines. Journal of Family Practice, 54(9), 789-800.
39. Bandelow, B., Seidler-Brandler, U., Becker, A., Wedekind, D., & Rüther, E. (2007). Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World Journal of Biological Psychiatry, 8(3), 175-187.
40. Ernst, E. (2002). “Flower remedies”: A systematic review of the clinical evidence. Wiener Klinische Wochenschrift, 114(23-24), 963-966.
41. Hammerness, P., Basch, E., Ulbricht, C., Barrette, E. -., Foppa, I., Basch, S., et al. (2003). St. john’s wort: A systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics, 44(4), 271-282.
42. Smith, T. B., Bartz, J., & Richards, P. S. (2007). Outcomes of religious and spiritual adaptations to psychotherapy: A meta-analytic review. Psychotherapy Research, 17(6), 643-655.
43. Deshmukh, V. M., Toelle, B. G., Usherwood, T., O’Grady, B., & Jenkins, C. R. (2007). Anxiety, panic and adult asthma: A cognitive-behavioral perspective. Respiratory Medicine, 101(2), 194-202.
44. Ernst, E. (2006). Herbal remedies for anxiety – A systematic review of controlled clinical trials. Phytomedicine, 13(3), 205-208.
45. Sarris, J. (2007). Herbal medicines in the treatment of psychiatric disorders: A systematic review. Phytotherapy Research, 21(8), 703-716.
46. Witte, S., Loew, D., & Gaus, W. (2005). Meta-analysis of the efficacy of the acetonic kava-kava extract WS®1490 in patients with non-psychotic anxiety disorders. Phytotherapy Research, 19(3), 183-188.
47. Rosenbaum, J. F., O’Brien, C. P., Otto, M. W., Pollack, M. H., Roy-Byrne, P. P., & Stewart, S. A. (2005). Benzodiazepines: Revisiting clinical issues in treating anxiety disorders. Primary Care Companion to the Journal of Clinical Psychiatry, 7(1), 23-31.
48. Spek, V., Cuijpers, P., NykIíček, I., Riper, H., Keyzer, J., & Pop, V. (2007). Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: A meta-analysis. Psychological Medicine, 37(3), 319-328.
49. Norton, P. J., & Price, E. C. (2007). A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. Journal of Nervous and Mental Disease, 195(6), 521-531.
50. Callaghan, P. (2004). Exercise: A neglected intervention in mental health care? Journal of Psychiatric and Mental Health Nursing, 11(4), 476-483.
51. Zwanzger, P., & Rupprecht, R. (2005). Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder. Journal of Psychiatry and Neuroscience, 30(3), 167-175.
52. Martin, J. L. R., Sainz-Pardo, M., Furukawa, T. A., Martin-Sanchez, E., Seoane, T., & Galan, C. (2007). Review: Benzodiazepines in generalized anxiety disorder: Heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. Journal of Psychopharmacology, 21(7), 774-782.
53. Compton, S. N., March, J. S., Brent, D., Albano, A. M., Weersing, V. R., & Curry, J. (2004). Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: An evidence-based medicine review. Journal of the American Academy of Child and Adolescent Psychiatry, 43(8), 930-959.
54. Malhi, G. S., Loo, C., Cahill, C. M., Lagopoulos, J., Mitchell, P., & Sachdev, P. (2006). “Getting physical”: The management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatric Disease and Treatment, 2(2), 165-179.
55. Neil, A. L., & Christensen, H. (2007). Australian school-based prevention and early intervention programs for anxiety and depession: A systematic review. Medical Journal of Australia, 186(6), 305-308.
56. Jorm, A. F., Christensen, H., Griffiths, K. M., Parslow, R. A., Rodgers, B., & Blewitt, K. A. (2004). Effectiveness of complementary and self-help treatments for anxiety disorders. Medical Journal of Australia, 181(7 SUPPL.), S29-S46.
57. Fergusson, D., Doucette, S., Glass, K. C., Shapiro, S., Healy, D., Hebert, P., et al. (2005). Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials. British Medical Journal, 330(7488), 396-399.
58. Wetherell, J. L., Sorrell, J. T., Thorp, S. R., & Patterson, T. L. (2005). Psychological interventions for late-life anxiety: A review and early lessons from the CALM study. Journal of Geriatric psychiatry and Neurology, 18(2), 72-82.